A novel clinically relevant antagonistic interplay between prolactin and oncogenic YAP-CCN2 pathways as a differentiation therapeutic target in breast cancer.
催乳素与致癌 YAP-CCN2 通路之间一种新的具有临床意义的拮抗作用，可作为乳腺癌分化治疗靶点
期刊:Cell Death & Disease
影响因子:9.6
doi:10.1038/s41419-025-07547-7
Liu Xueqing, Moamer Alaa, Gomes da Silva Roger, Shoham-Amizlev Aidan, Hamam Dana, Shams Anwar, Lebrun Jean-Jacques, Ali Suhad
